Product Information

SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR is a brand biologic product labeled by Teva Pharmaceuticals USA Inc., priced at $498.5458 per EA under NDC 51759040217. Its NADAC has been published 83 times since Apr 23, 2025.

SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR

adalimumab-ryvk
$498.5458per EA

NDC

51759040217

Classification

Brand Biologic

Dosage Form

KIT

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Approval Type

Biologic (BLA)

FDA Application

BLA761299

On Market Since

5/20/2024

Price Statistics

The NADAC for SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR has been published 83 times since Apr 23, 2025, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.

Current price$498.5458 per EA
All-time high$499.2516 (Nov 11, 2026)
All-time low$479.2713 (Jul 23, 2025)
52-week high$499.2516
52-week low$484.8925
Median price$486.4770
Average price$487.4162
Largest weekly change+1.1% (Sep 23, 2026)
Weeks tracked83
Tracking sinceApr 23, 2025

Price History

1W

-0.1%

1M

-0.1%

3M

+1.0%

6M

+1.5%

1Y

+2.8%

3Y

N/A

5Y

N/A

All

+3.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR?

The current National Average Drug Acquisition Cost (NADAC) for SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR, manufactured by Teva Pharmaceuticals USA Inc., is $498.5458 per EA (NDC 51759040217), effective Nov 18, 2026.

How has the price of SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR changed over time?

Over the history we have for it, the NADAC for SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR has risen 3.2%. It has been tracked across 83 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR?

Since Apr 23, 2025, the NADAC for SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR has ranged from a low of $479.2713 (Jul 23, 2025) to a high of $499.2516 (Nov 11, 2026), with a median of $486.4770 per EA.

Are there cheaper alternatives to SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR in a comparable dosage form, but none are currently priced below it.

Who manufactures SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR?

SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR (NDC 51759040217) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand biologic product.